• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Another day, another scandal









Who cares?

Everyone should care, especially shareholders. What she describes is rampant and part of our culture. Nobody creates anything, everyone advances by forming relationships and keeping others down.

The only untrue part of the article is the following: "....the company is "committed to fostering and promoting a culture of diversity and respect, and a work environment free of discrimination, harassment or retaliation of any kind.""